Drug Interactions Database

944 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

dronedarone cariprazine

increases exposure

Severe Study

dronedarone dabigatran

increases exposure

Severe Study

dronedarone domperidone

increases exposure

Severe Study

dronedarone lomitapide

increases exposure

Severe Theoretical

dronedarone quetiapine

increases exposure

Severe Study

dronedarone rupatadine

increases exposure

Severe Study

dronedarone thrombininhibitors

increases exposure

Severe Study

dronedarone tricyclicantidepressants

increases exposure

Severe Theoretical

droperidol dopaminereceptoragonists

decreases effects

Severe Theoretical

efavirenz antimalarials

decreases exposure

Severe Study

efavirenz atovaquone

decreases exposure

Severe Study

efavirenz benzodiazepines

affects effects

Severe Theoretical

efavirenz midazolam

affects effects

Severe Theoretical

efavirenz posaconazole

decreases exposure

Severe Study

endothelinreceptorantagonistsarepredictedto decreasetheconcentrationofsirolimusandsirolimus bosentan

increases concentration

Severe Theoretical

endothelinreceptorantagonistsarepredictedto decreasetheconcentrationofsirolimusandsirolimus endothelinreceptorantagonists

increases concentration

Severe Theoretical

endothelinreceptorantagonistsarepredictedto decreasetheconcentrationoftacrolimusandtacrolimus bosentan

increases concentration

Severe Theoretical

endothelinreceptorantagonistsarepredictedto decreasetheconcentrationoftacrolimusandtacrolimus endothelinreceptorantagonists

increases concentration

Severe Theoretical

endothelinreceptorantagonistsmoderatelydecrease theexposuretociclosporinandciclosporinmoderately bosentan

increases exposure

Severe Study

endothelinreceptorantagonistsmoderatelydecrease theexposuretociclosporinandciclosporinmoderately endothelinreceptorantagonists

increases exposure

Severe Study

ergometrine dopamine

increases risk of peripheralvasoconstriction

Severe Anecdotal

ergometrine sympathomimetics,inotropic

increases risk of peripheralvasoconstriction

Severe Anecdotal

erythromycin antipsychotics,secondgeneration

increases exposure

Severe Study

erythromycin cariprazine

increases exposure

Severe Study

erythromycin eletriptan

increases exposure

Severe Study

erythromycin ivabradine

increases exposure

Severe Theoretical

erythromycin lomitapide

increases exposure

Severe Theoretical

erythromycin pimozide

increases exposure

Severe Theoretical

erythromycin quetiapine

increases exposure

Severe Study

erythromycin simvastatin

increases exposure

Severe Study

erythromycin triptans

increases exposure

Severe Study

esketamine ergometrine

increases risk of elevatedbloodpressure

Severe Theoretical

etonogestrel ulipristalandulipristalmightdecreasetheefficacyofetonogestrel

decreases efficacy

Severe Theoretical

etravirine benzodiazepines

increases exposure

Severe Theoretical

etravirine diazepam

increases exposure

Severe Theoretical

etravirine mobocertinib

decreases exposure

Severe Theoretical

etravirine zanubrutinib

decreases exposure

Severe Theoretical

febuxostat azathioprine

increases exposure

Severe Theoretical

febuxostat mercaptopurine

increases exposure

Severe Theoretical

fenofibrate pravastatin

increases risk of rhabdomyolysis

Severe Theoretical

fibrates irinotecan

increases exposure

Severe Theoretical

fibrates pravastatin

increases risk of rhabdomyolysis

Severe Theoretical

fibrates ursodeoxycholicacid

decreases efficacy

Severe Theoretical

filgotinib abatacept